Produktbild: Clinical Proteomics

Clinical Proteomics From Diagnosis to Therapy

519,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.11.2007

Abbildungen

schwarz-weiss Illustrationen, Tabellen, schwarz-weiss, farbige Illustrationen

Herausgeber

Jennifer E. Van Eyk + weitere

Verlag

Wiley-VCH

Seitenzahl

694

Maße (L/B/H)

24,6/18,2/4 cm

Gewicht

1422 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-527-31637-3

Beschreibung

Rezension

"The editors have assembled 136 authors, all leaders in the field, to contribute 34 chapters outlining collective knowledge that has been gained over the last several years into a single resource book. This book is a description of science in the making." ( Journal of Tropical Pediatrics , February 2009)
"Das Buch zeigt in einer sehr eindrucksvollen Gesamtschau, dass die Proteomik ein interessanter Ansatz ist, um die Diagnostik und Therapie zu verbessern.?Pharmazie in unserer Zeit Februar 2008"Eine Zusammenstellung des aktuellen Wissenstands gibt das kürzlich erschienene Buch"Pharmazie in unserer Zeit, Februar 2008

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.11.2007

Abbildungen

schwarz-weiss Illustrationen, Tabellen, schwarz-weiss, farbige Illustrationen

Herausgeber

Verlag

Wiley-VCH

Seitenzahl

694

Maße (L/B/H)

24,6/18,2/4 cm

Gewicht

1422 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-527-31637-3

Herstelleradresse

Wiley-VCH GmbH
Boschstr. 12
69469 Weinheim
Deutschland
Email: trade@wiley.com
Url: www.wiley-vch.de
Fax: +49 6201 606328

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Clinical Proteomics
  • Editors Overview

    PART 1: TECHNOLOGIES
    Pre-analytical issues in clinical proteomic studies
    Protein separation by 2DE
    Protein separation : liquid chromatography
    HPLC in protein discovery
    IEF analysis of peptides for biomarkers analysis
    Capillary electrophoresis separations for clinical proteomics
    Quantitative proteomics using nanoLC with high accuracy mass spectrometry
    Antibody microarrays for protein and glycan detection
    Biomarker Identification: The Role of Experimental Design, Statistics, and Data Sharing
    PART 2: CANCER
    Applications of stable isotope tagging based quantitive proteomics in cancer research
    2-D liquid seperations, protein microarrays and mass spectrometry in comprehensive analysis of PTM and biomarker discovery
    Development and Use of Reversed-Phase Protein Microarrays for Clinical Applications
    CDK1 and cancer: usefulness of proteomic approaches in assesment of the molecular mechanisms and efficacy of novel therapeutics
    PART 3: CARDIOVASCULAR DISEASE
    Diagnostic markers for monitoring heart transplant rejection
    The study of microheterogeneity in human plasma proteins: applications to acute myocardial infarction
    Discovery of biomarkers for cardiovascular diseases
    Development of biomarker Developfment Pipeline: Search for Myocardial Ischemia Biomarkers
    Albuminome as a tool for biomarker discovery
    PART 4: VASCULAR DISEASES
    Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery
    Urinary biomarkers in diabetic nephropathy and other glomerular diseases
    Pulmonary proteomics
    Proteomics providing insights into major psychiatric disorders
    PART 6: BIOMARKERS
    Redox Proteomics Analysis of Oxidative Modified Brain Proteins in Alzheimer´s Disease and Mild Cognitive Impairment: Insights into the Progression of This Dementing Disorder
    Toxicoproteomics: correlating tissue and serum proteins in liver injuries
    Biomarkers for renal disease and uraemic toxins
    HIV and other viral screens
    PART 6: AUTOANTIBODIES AND SIGNATURE BIOMARKERS
    Application of Fungal Cyclic Peptides and Metabolites
    Microarray approaches to autoantibody profiling
    Identification of tumor antigen-directed autoantibodies
    PART 7: FUTURE
    Antibody and Reverse Capture Protein Microarrays
    Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases
    The Future: Translation from Discovery to the Clinic - Roles of HUPO and industry in biomarker discovery